COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Arthur Klausner will participate on a panel at the Biotechnology Entrepreneurship Boot Camp program that is associated with the the BIO International Convention in San Diego, CA
News | 06. 17. 2008
